Panelists discuss how: LDL-C control remains a national crisis, with many patients not on therapy or failing to reach target ...

Panelists discuss how: clinical inertia, patient apathy, and the asymptomatic nature of high cholesterol all contribute to undertreatment and poor outcomes.

Elevated lipids increased rates of obstetrical and cardiovascular adverse events over a 5-year follow-up period.

An expert discusses how underutilization of combination lipid-lowering therapies stems from overly complex guidelines, ...

Researchers have uncovered a simple magnesium-based score that could help identify which high-cholesterol patients are most likely to face deadly heart problems, years before symptoms appear. Study: ...

Preexisting hyperlipidemia in pregnancy is associated with heightened risks of obstetric complications and early ...

I am looking for information on the use of inositol hexaniacinate ("no-flush niacin") in the treatment of hyperlipidemia. Most of the information I have been able to find is anecdotal. I understand ...

American Journal of Health-System Pharmacy. 2005;62(16):1690-1692. A 62-year-old Caucasian man arrived at an ambulatory care clinic in August 2003 for hyperlipidemia follow-up. One of the patient's ...

The role of hyperlipidemia as a risk factor for stroke is unclear. A new retrospective study has examined the relationship between a history of hyperlipidemia and MRI-defined white matter ...

Research led by Baylor College of Medicine has shown that a new therapy significantly reduces triglyceride levels in individuals with mixed hyperlipidemia – elevations of triglycerides and cholesterol ...

Please provide your email address to receive an email when new articles are posted on . “PCOS patients are at increased risk of metabolic conditions, even patients who were in the non-obese range,” ...